Physician

Christopher Luminais, M.D.

According to 2025 Medicare claims, Christopher Luminais, M.D. (NPI: 1184157794) practices radiation oncology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Albemarle, VA. This provider's primary affiliated billing organization is UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (NPI: 1033138250; TIN: 541124769) and primary practice location at 22908-0817.

Luminais' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 3,864 HCPCS/CPT codes, and received $268,972 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 492 prescription claims across 170 beneficiaries totaling $159,684 in drug costs, led by Orgovyx (Relugolix). Open Payments data shows 3 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,069 to $159,684. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$134K$269K2022 Medicare payment: $42,340 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $253,767 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $268,972 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022178496$42,340
20234483,120$253,767
20245263,864$268,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$80K$160K2018 Drug cost: $1,069 (USD; Tot_Drug_Cst)2019 Drug cost: $4,029 (USD; Tot_Drug_Cst)2020 Drug cost: $5,333 (USD; Tot_Drug_Cst)2021 Drug cost: $1,486 (USD; Tot_Drug_Cst)2022 Drug cost: $1,260 (USD; Tot_Drug_Cst)2023 Drug cost: $73,305 (USD; Tot_Drug_Cst)2024 Drug cost: $159,684 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182753$1,069
20194692$4,029
202061108$5,333
20214375$1,486
20223253$1,260
202393247$73,305
2024170492$159,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more174174$126
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more122170$47
77014Ct guidance for insertion of radiation therapy fields1711,175$34
77300Calculation of radiation therapy dose121362$25
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's283427$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrgovyxRelugolix541,726$147,596
Tamsulosin HclTamsulosin Hcl25319,740$3,045
Alfuzosin Hcl ErAlfuzosin Hcl231,755$561
Oxybutynin Chloride ErOxybutynin Chloride11990$501
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim29203$51

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$417Elekta, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Luminais, M.D.?

Tedicare shows public-source Medicare data for Christopher Luminais, M.D. (NPI 1184157794), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Luminais, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Luminais, M.D.?

Christopher Luminais, M.D. is linked to UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (billing NPI 1033138250) in the available physician profile data.

Does Christopher Luminais, M.D. have Open Payments data?

Christopher Luminais, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.